1. Home
  2. DYN vs RNW Comparison

DYN vs RNW Comparison

Compare DYN & RNW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DYN
  • RNW
  • Stock Information
  • Founded
  • DYN 1984
  • RNW 2011
  • Country
  • DYN United States
  • RNW United Kingdom
  • Employees
  • DYN N/A
  • RNW N/A
  • Industry
  • DYN Medicinal Chemicals and Botanical Products
  • RNW Electric Utilities: Central
  • Sector
  • DYN Health Care
  • RNW Utilities
  • Exchange
  • DYN Nasdaq
  • RNW Nasdaq
  • Market Cap
  • DYN 2.6B
  • RNW 2.2B
  • IPO Year
  • DYN 2020
  • RNW N/A
  • Fundamental
  • Price
  • DYN $9.23
  • RNW $5.84
  • Analyst Decision
  • DYN Strong Buy
  • RNW Strong Buy
  • Analyst Count
  • DYN 12
  • RNW 1
  • Target Price
  • DYN $47.73
  • RNW $7.50
  • AVG Volume (30 Days)
  • DYN 1.8M
  • RNW 779.6K
  • Earning Date
  • DYN 05-01-2025
  • RNW 02-18-2025
  • Dividend Yield
  • DYN N/A
  • RNW N/A
  • EPS Growth
  • DYN N/A
  • RNW N/A
  • EPS
  • DYN N/A
  • RNW 0.04
  • Revenue
  • DYN N/A
  • RNW $1,006,524,942.00
  • Revenue This Year
  • DYN N/A
  • RNW N/A
  • Revenue Next Year
  • DYN N/A
  • RNW $38.75
  • P/E Ratio
  • DYN N/A
  • RNW $150.13
  • Revenue Growth
  • DYN N/A
  • RNW N/A
  • 52 Week Low
  • DYN $9.17
  • RNW $5.15
  • 52 Week High
  • DYN $47.45
  • RNW $7.49
  • Technical
  • Relative Strength Index (RSI)
  • DYN 26.62
  • RNW 34.77
  • Support Level
  • DYN $10.72
  • RNW $6.09
  • Resistance Level
  • DYN $12.00
  • RNW $6.29
  • Average True Range (ATR)
  • DYN 0.76
  • RNW 0.13
  • MACD
  • DYN -0.11
  • RNW -0.02
  • Stochastic Oscillator
  • DYN 1.52
  • RNW 14.95

About DYN Dyne Therapeutics Inc.

Dyne Therapeutics Inc is a biotechnology company focused on providing therapeutics for patients with genetically driven diseases. The company overcomes the limitations of muscle tissue delivery and modern oligonucleotide therapeutics for muscle diseases. The company is developing therapies for muscle disorders like Myotonic dystrophy, Duchenne muscular dystrophy, and Facioscapulohumeral muscular dystrophy. The company's product candidates are DYNE-101 and DYNE-251, both are in the ongoing phase 1/2 clinical trial.

About RNW ReNew Energy Global plc

ReNew Energy Global PLC is a developer and operator of clean energy projects intended to meet India's growing energy needs in an efficient, sustainable and socially responsible manner. The company provides end-to-end solutions in a just and inclusive manner in the areas of clean energy, value-added energy offerings through digitalization, storage, and carbon markets that increasingly are integral to addressing climate change. The company has four reportable segments: wind power and solar power, hydro power and transmission line. It derives maximum revenue from Wind Power segment.

Share on Social Networks: